EGM
SPRY icon

Engineers Gate Manager’s ARS Pharmaceuticals SPRY Stock Holding History

Engineers Gate Manager’s Portfolio SPRY Stock Details SPRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.12M Buy
139,419
+92,163
+195% +$793K 0.01% 1019
2026
Q1 		$379K Buy
+47,256
New +$453K ﹤0.01% 1577
2025
Q2 		– Sell
-18,583
Closed -$234K – 2513
2025
Q1 		$234K Buy
18,583
+2,224
+14% +$26.8K ﹤0.01% 1827
2024
Q4 		$173K Buy
+16,359
New +$229K ﹤0.01% 1914

Other funds holding SPRY

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tyro Capital Management Miami, Florida $446M AUM 84.15% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Engineers Gate Manager's SPRY Position: Q2 2026 in Review

Engineers Gate Manager increased its ARS Pharmaceuticals (SPRY) stake by 195% in Q2 2026, buying an estimated $793K and bringing the position to 139,419 shares worth $1.12M. The position accounts for 0.01% of the portfolio, ranked #1019.

Engineers Gate Manager first reported a position in SPRY in Q4 2024 and has held it in 4 quarters since. 209 funds tracked by Wall St. Rank hold SPRY as of Q2 2026.

  • Engineers Gate Manager held 139,419 shares of ARS Pharmaceuticals worth $1.12M as of Q2 2026.
  • Engineers Gate Manager bought 92,163 ARS Pharmaceuticals shares in Q2 2026, an estimated $793K.
  • ARS Pharmaceuticals made up 0.01% of Engineers Gate Manager's portfolio in Q2 2026, its #1019 holding.
  • Engineers Gate Manager first reported a position in ARS Pharmaceuticals in Q4 2024 and has held it in 4 quarters since.
  • 209 funds tracked by Wall St. Rank held ARS Pharmaceuticals as of Q2 2026.

Based on Engineers Gate Manager's 13F filing for Q2 2026, filed 14 Aug 2026.